{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:58:08Z","timestamp":1788620288247,"version":"build-2803163510"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003510","name":"Estonian Ministry of Education and Research","doi-asserted-by":"crossref","award":["IUT34-16"],"award-info":[{"award-number":["IUT34-16"]}],"id":[{"id":"10.13039\/501100003510","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006598","name":"Enterprise Estonia","doi-asserted-by":"crossref","award":["EU48695"],"award-info":[{"award-number":["EU48695"]}],"id":[{"id":"10.13039\/501100006598","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Union\u2019s Horizon 2020","award":["857418"],"award-info":[{"award-number":["857418"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteogenesis Imperfecta (OI) is a rare genetic disorder involving bone fragility. OI patients typically suffer from numerous fractures, skeletal deformities, shortness of stature and hearing loss. The disorder is characterised by genetic and clinical heterogeneity. Pathogenic variants in more than 20 different genes can lead to OI, and phenotypes can range from mild to lethal forms. As a genetic disorder which undoubtedly affects quality of life, OI significantly alters the reproductive confidence of families at risk. The current review describes a selection of the latest reproductive approaches which may be suitable for prospective parents faced with a risk of OI. The aim of the review is to alleviate suffering in relation to family planning around OI, by enabling prospective parents to make informed and independent decisions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body<\/jats:title>\n                <jats:p>The current review provides a comprehensive overview of possible reproductive options for people with OI and for unaffected carriers of OI pathogenic genetic variants. The review considers reproductive options across all phases of family planning, including pre-pregnancy, fertilisation, pregnancy, and post-pregnancy. Special attention is given to the more modern techniques of assisted reproduction, such as preconception carrier screening, preimplantation genetic testing for monogenic diseases and non-invasive prenatal testing. The review outlines the methodologies of the different reproductive approaches available to OI families and highlights their advantages and disadvantages. These are presented as a decision tree, which takes into account the autosomal dominant and autosomal recessive nature of the OI variants, and the OI-related risks of people without OI.<\/jats:p>\n                <jats:p>The complex process of decision-making around OI reproductive options is also discussed from an ethical perspective.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The rapid development of molecular techniques has led to the availability of a wide variety of reproductive options for prospective parents faced with a risk of OI. However, such options may raise ethical concerns in terms of methodologies, choice management and good clinical practice in reproductive care, which are yet to be fully addressed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-01404-w","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T11:03:40Z","timestamp":1590577420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Reproductive options for families at risk of Osteogenesis Imperfecta: a review"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-0402","authenticated-orcid":false,"given":"Lidiia","family":"Zhytnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadri","family":"Simm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Salumets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maire","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aare","family":"M\u00e4rtson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katre","family":"Maasalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"1404_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1641\/0006-3568(2000)050[0245:TMOL]2.3.CO;2","volume":"50","author":"L Chao","year":"2000","unstructured":"Chao L. The meaning of life. Bioscience. 2000;50:245\u201350 Narnia.","journal-title":"Bioscience"},{"key":"1404_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/01443615.2017.1347916","volume":"38","author":"OP Aduloju","year":"2018","unstructured":"Aduloju OP, Olaogun OD, Aduloju T. Quality of life in women of reproductive age: a comparative study of infertile and fertile women in a Nigerian tertiary centre. J Obstet Gynaecol (Lahore). 2018;38:247\u201351 Taylor and Francis Ltd.","journal-title":"J Obstet Gynaecol (Lahore)"},{"key":"1404_CR3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.15252\/embr.201744253","volume":"18","author":"J Geraedts","year":"2017","unstructured":"Geraedts J. Healthy children without fear. EMBO Rep. 2017;18:666\u20139.","journal-title":"EMBO Rep"},{"key":"1404_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s004390000298","volume":"106","author":"A De Vos","year":"2000","unstructured":"De Vos A, Sermon K, Van De Velde H, Joris H, Vandervorst M, Lissens W, et al. Two pregnancies after preimplantation genetic diagnosis for osteogenesis imperfecta type I and type IV. Hum Genet. 2000;106:605\u201313 Springer Verlag.","journal-title":"Hum Genet"},{"key":"1404_CR5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s10038-018-0489-9","volume":"63","author":"X Yin","year":"2018","unstructured":"Yin X, Du Y, Zhang H, Wang Z, Wang J, Fu X, et al. Identification of a de novo fetal variant in osteogenesis imperfecta by targeted sequencing-based noninvasive prenatal testing. J Hum Genet. 2018;63:1129\u201337 Nature Publishing Group.","journal-title":"J Hum Genet"},{"key":"1404_CR6","doi-asserted-by":"publisher","first-page":"S589","DOI":"10.1016\/j.ajog.2018.11.936","volume":"220","author":"P Mohan","year":"2019","unstructured":"Mohan P, Parmar S, Saucier J, Jelsema R, Eaves K, Thomsen A, et al. 912: skeletal dysplasias screening by NIPT for single-gene disorders: clinical value of narrowing the differential diagnosis. Am J Obstet Gynecol. 2019;220:S589 Elsevier BV.","journal-title":"Am J Obstet Gynecol"},{"key":"1404_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejmg.2015.01.004","volume":"58","author":"IB Mathijssen","year":"2015","unstructured":"Mathijssen IB, Henneman L, van Eeten-Nijman JMC, Lakeman P, Ottenheim CPE, Redeker EJW, et al. Targeted carrier screening for four recessive disorders: high detection rate within a founder population. Eur J Med Genet. 2015;58:123\u20138 Elsevier Masson SAS.","journal-title":"Eur J Med Genet"},{"key":"1404_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev.me.43.020192.001413","volume":"43","author":"PH Byers","year":"1992","unstructured":"Byers PH, Steiner RD. Osteogenesis imperfecta. Annu Rev Med. 1992;43:269\u201382.","journal-title":"Annu Rev Med"},{"key":"1404_CR9","first-page":"113","volume":"15","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Rimoin DL, Danks DM. Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity. Birth Defects Orig Artic Ser. 1979;15:113\u201329.","journal-title":"Birth Defects Orig Artic Ser"},{"key":"1404_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1177\/000348940211101014","volume":"111","author":"K Kuurila","year":"2002","unstructured":"Kuurila K, Johansson R, Kaitila I, Gr\u00e9nman R. Hearing loss in Finnish adults with Osteogenesis Imperfecta: a nationwide survey. Ann Otol Rhinol Laryngol. 2002;111:939\u201346.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"1404_CR11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/ejhg.2015.81","volume":"23","author":"K Lindahl","year":"2015","unstructured":"Lindahl K, \u00c5str\u00f6m E, Rubin C-J, Grigelioniene G, Malmgren B, Ljunggren \u00d6, et al. Genetic epidemiology, prevalence, and genotype\u2013phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet. 2015;23:1042\u201350.","journal-title":"Eur J Hum Genet"},{"key":"1404_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.22203\/eCM.v005a04","volume":"5","author":"PJ Roughley","year":"2003","unstructured":"Roughley PJ, Rauch F, Glorieux FH. Osteogenesis imperfecta--clinical and molecular diversity. Eur Cell Mater. 2003;5:41\u20137 discussion 47.","journal-title":"Eur Cell Mater"},{"key":"1404_CR13","first-page":"27","volume":"36","author":"JA Buckwalter","year":"1987","unstructured":"Buckwalter JA, Cooper RR. Bone structure and function. Instr Course Lect. 1987;36:27\u201348.","journal-title":"Instr Course Lect"},{"key":"1404_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1359\/jbmr.090720","volume":"25","author":"E Daley","year":"2010","unstructured":"Daley E, Streeten EA, Sorkin JD, Kuznetsova N, Shapses SA, Carleton SM, et al. Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model. J Bone Miner Res. 2010;25:247\u201361.","journal-title":"J Bone Miner Res"},{"key":"1404_CR15","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/jbmr.1891","volume":"28","author":"JR Shapiro","year":"2013","unstructured":"Shapiro JR, Lietman C, Grover M, Lu JT, Nagamani SC, Dawson BC, et al. Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation. J Bone Miner Res. 2013;28:1523\u201330 Wiley-Blackwell.","journal-title":"J Bone Miner Res"},{"key":"1404_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/GIM.0b013e3181a1ff7b","volume":"11","author":"D Basel","year":"2009","unstructured":"Basel D, Steiner RD. Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition. Genet Med. 2009;11:375\u201385.","journal-title":"Genet Med"},{"key":"1404_CR17","first-page":"CD005088","volume-title":"Cochrane Database Syst. Rev","author":"K Dwan","year":"2014","unstructured":"Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. In: Basel D, editor. Cochrane Database Syst. Rev. Chichester: Wiley; 2014. p. CD005088."},{"key":"1404_CR18","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini JC, Forlino A, B\u00e4chinger HP, Bishop NJ, Byers PH, De Paepe A, et al. Osteogenesis imperfecta. Nat Rev Dis Prim. 2017;3:17052 Nature Publishing Group.","journal-title":"Nat Rev Dis Prim"},{"key":"1404_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/JMDH.S113483","volume":"10","author":"C Marr","year":"2017","unstructured":"Marr C, Seasman A, Bishop N. Managing the patient with osteogenesis imperfecta: a multidisciplinary approach. J Multidiscip Healthc. 2017;10:145\u201355 Dove Press.","journal-title":"J Multidiscip Healthc"},{"key":"1404_CR20","first-page":"367","volume":"6","author":"E Monti","year":"2010","unstructured":"Monti E, Mottes M, Fraschini P, Brunelli P, Forlino A, Venturi G, et al. Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag. 2010;6:367\u201381 Dove Press.","journal-title":"Ther Clin Risk Manag"},{"key":"1404_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000381713","volume":"84","author":"EBG Rijks","year":"2015","unstructured":"Rijks EBG, Bongers BC, Vlemmix MJG, Boot AM, Van Dijk ATH, Sakkers RJB, et al. Efficacy and safety of bisphosphonate therapy in children with osteogenesis imperfecta: a systematic review. Horm Res Paediatr. 2015;84:26\u201342.","journal-title":"Horm Res Paediatr"},{"key":"1404_CR22","first-page":"183","volume":"12","author":"O Semler","year":"2012","unstructured":"Semler O, Netzer C, Hoyer-Kuhn H, Becker J, Eysel P, Schoenau E. First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI. J Musculoskelet Neuronal Interact. 2012;12:183\u20138.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"1404_CR23","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/s41431-019-0387-4","volume":"27","author":"M Hill","year":"2019","unstructured":"Hill M, Lewis C, Riddington M, Crowe B, DeVile C, David AL, et al. Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta. Eur J Hum Genet. 2019;27:1244\u201353 Nature Publishing Group.","journal-title":"Eur J Hum Genet"},{"key":"1404_CR24","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.bbadis.2018.02.002","volume":"1864","author":"R Besio","year":"2018","unstructured":"Besio R, Iula G, Garibaldi N, Cipolla L, Sabbioneda S, Biggiogera M, et al. 4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1642\u201352 Elsevier B.V.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1404_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s002640100292","volume":"26","author":"RF Widmann","year":"2002","unstructured":"Widmann RF, Laplaza FJ, Bitan FD, Brooks CE, Root L. Quality of life in osteogenesis imperfecta. Int Orthop. 2002;26:3\u20136.","journal-title":"Int Orthop"},{"key":"1404_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ajmg.a.37377","volume":"170","author":"N Dahan-Oliel","year":"2016","unstructured":"Dahan-Oliel N, Oliel S, Tsimicalis A, Montpetit K, Rauch F, Dogba MJ. Quality of life in osteogenesis imperfecta: a mixed-methods systematic review. Am J Med Genet A. 2016;170:62\u201376 Wiley-Blackwell.","journal-title":"Am J Med Genet A"},{"key":"1404_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7525-12-54","volume":"12","author":"CL Hill","year":"2014","unstructured":"Hill CL, Baird WO, Walters SJ. Quality of life in children and adolescents with Osteogenesis Imperfecta: a qualitative interview based study. Health Qual Life Outcomes. 2014;12:54 BioMed Central.","journal-title":"Health Qual Life Outcomes"},{"key":"1404_CR28","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/jbmr.2895","volume":"31","author":"L Folkestad","year":"2016","unstructured":"Folkestad L, Hald JD, Canudas-Romo V, Gram J, Hermann AP, Langdahl B, et al. Mortality and causes of death in patients with Osteogenesis Imperfecta: a register-based nationwide cohort study. J Bone Miner Res. 2016;31:2159\u201366.","journal-title":"J Bone Miner Res"},{"key":"1404_CR29","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","volume":"164A","author":"FS Van Dijk","year":"2014","unstructured":"Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014;164A:1470\u201381.","journal-title":"Am J Med Genet A"},{"key":"1404_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ajmg.1320170204","volume":"17","author":"DO Sillence","year":"1984","unstructured":"Sillence DO, Barlow KK, Garber AP, Hall JG, Rimoin DL. Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet. 1984;17:407\u201323.","journal-title":"Am J Med Genet"},{"key":"1404_CR31","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","volume":"15","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, et al. Type V Osteogenesis Imperfecta: a new form of brittle bone disease. J Bone Miner Res. 2000;15:1650\u20138 John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR).","journal-title":"J Bone Miner Res"},{"key":"1404_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/cge.12409","volume":"87","author":"RM Patel","year":"2015","unstructured":"Patel RM, Nagamani SCS, Cuthbertson D, Campeau PM, Krischer JP, Shapiro JR, et al. A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers. Clin Genet. 2015;87:133\u201340 Blackwell Publishing Ltd.","journal-title":"Clin Genet"},{"key":"1404_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40246-019-0209-3","volume":"13","author":"L Zhytnik","year":"2019","unstructured":"Zhytnik L, Maasalu K, Duy BH, Pashenko A, Khmyzov S, Reimann E, et al. IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients. Hum Genomics. 2019;13:25 BioMed Central.","journal-title":"Hum Genomics"},{"key":"1404_CR34","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1007\/s00198-016-3709-1","volume":"27","author":"G Bardai","year":"2016","unstructured":"Bardai G, Moffatt P, Glorieux FH, Rauch F. DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum. Osteoporos Int. 2016;27:3607\u201313.","journal-title":"Osteoporos Int"},{"key":"1404_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101\u201316.","journal-title":"J Med Genet"},{"key":"1404_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40246-017-0115-5","volume":"11","author":"L Zhytnik","year":"2017","unstructured":"Zhytnik L, Maasalu K, Reimann E, Prans E, K\u00f5ks S, M\u00e4rtson A. Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients. Hum Genomics. 2017;11:19.","journal-title":"Hum Genomics"},{"issue":"7","key":"1404_CR37","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41431-019-0373-x","volume":"27","author":"Margherita Maioli","year":"2019","unstructured":"Maioli M, Gnoli M, Boarini M, Tremosini M, Zambrano A, Pedrini E, et al. Genotype\u2013phenotype correlation study in 364 osteogenesis imperfecta Italian patients. Eur J Hum Genet. 2019;27:1090\u2013100. https:\/\/doi.org\/10.1038\/s41431-019-0373-x.","journal-title":"European Journal of Human Genetics"},{"key":"1404_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/humu.20429","volume":"28","author":"JC Marini","year":"2007","unstructured":"Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat. 2007;28:209\u201321.","journal-title":"Hum Mutat"},{"key":"1404_CR39","first-page":"130","volume-title":"Osteogenes. Imperfecta","author":"EM Leikin","year":"2014","unstructured":"Leikin EM, S. Collagen Structure, Folding and Function. Osteogenes. Imperfecta; 2014. p. 130\u201351."},{"key":"1404_CR40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1146\/annurev.bi.53.070184.003441","volume":"53","author":"DR Eyre","year":"1984","unstructured":"Eyre DR, Paz MA, Gallop PM. Cross-linking in collagen and elastin. Annu Rev Biochem. 1984;53:717\u201348.","journal-title":"Annu Rev Biochem"},{"key":"1404_CR41","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1146\/annurev.biochem.77.032207.120833","volume":"78","author":"MD Shoulders","year":"2009","unstructured":"Shoulders MD, Raines RT. Collagen structure and stability. Annu Rev Biochem. 2009;78:929\u201358 NIH Public Access.","journal-title":"Annu Rev Biochem"},{"key":"1404_CR42","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrendo.2011.81","volume":"7","author":"A Forlino","year":"2011","unstructured":"Forlino A, Cabral WA, Barnes AM, Marini JC. New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 2011;7:540\u201357.","journal-title":"Nat Rev Endocrinol"},{"key":"1404_CR43","doi-asserted-by":"publisher","unstructured":"Dubail J, Brunelle P, Baujat G, Huber C, Doyard M, Michot C, et al. Homozygous loss-of-function mutations in CCDC134 are responsible for a severe form of osteogenesis imperfecta. J Bone Miner Res. 2020. https:\/\/doi.org\/10.1002\/jbmr.4011. [Epub ahead of print].","DOI":"10.1002\/jbmr.4011"},{"issue":"6","key":"1404_CR44","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00404-016-4012-2","volume":"293","author":"M Cozzolino","year":"2016","unstructured":"Cozzolino M, Perelli F, Maggio L, Coccia ME, Quaranta M, Gizzo S, et al. Management of osteogenesis imperfecta type I in pregnancy; a review of literature applied to clinical practice. Arch Gynecol Obstet. 2016;293(6):1153\u20139 Springer Verlag.","journal-title":"Arch Gynecol Obstet"},{"key":"1404_CR45","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s13256-019-2296-0","volume":"13","author":"F Chamunyonga","year":"2019","unstructured":"Chamunyonga F, Masendeke KL, Mateveke B. Osteogenesis imperfecta and pregnancy: a case report. J Med Case Rep. 2019;13:363 BioMed Central Ltd.","journal-title":"J Med Case Rep"},{"key":"1404_CR46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s10897-017-0160-1","volume":"27","author":"CE Ghiossi","year":"2018","unstructured":"Ghiossi CE, Goldberg JD, Haque IS, Lazarin GA, Wong KK. Clinical utility of expanded carrier screening: reproductive behaviors of at-risk couples. J Genet Couns. 2018;27:616\u201325.","journal-title":"J Genet Couns"},{"issue":"3","key":"1404_CR47","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1002\/mgg3.559","volume":"7","author":"L Zhytnik","year":"2019","unstructured":"Zhytnik L, Maasalu K, Duy BH, Pashenko A, Khmyzov S, Reimann E, et al. De novo and inherited pathogenic variants in collagen-related osteogenesis imperfecta. Mol Genet Genomic Med. 2019;7(3):e559.","journal-title":"Mol Genet Genomic Med"},{"key":"1404_CR48","unstructured":"The Voice of People with OI | OIFE - Osteogenesis Imperfecta Federation Europe. Available from: https:\/\/oife.org\/2018\/04\/02\/the-voice-of-people-with-oi\/. Cited 22 Oct 2019."},{"issue":"6","key":"1404_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/01.gim.0000223557.54670.aa","volume":"8","author":"PH Byers","year":"2006","unstructured":"Byers PH, Krakow D, Nunes ME, Pepin M. Genetic evaluation of suspected osteogenesis imperfecta (OI). Genet Med. 2006;8(6):383\u20138.","journal-title":"Genet Med"},{"key":"1404_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/ejhg.2011.141","volume":"20","author":"FS van Dijk","year":"2012","unstructured":"van Dijk FS, Byers PH, Dalgleish R, Malfait F, Maugeri A, Rohrbach M, et al. EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta. Eur J Hum Genet. 2012;20:11\u20139.","journal-title":"Eur J Hum Genet"},{"key":"1404_CR51","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bone.2018.02.029","volume":"110","author":"Julia Mrosk","year":"2018","unstructured":"Mrosk J, Gandham SB, Shah H, Hecht J, Kr\u00fcger U, Shukla A, et al. Diagnostic strategies and genotype-phenotype correlation in a large Indian cohort of osteogenesis imperfecta. Bone. 2018;110:368\u201377. https:\/\/doi.org\/10.1016\/j.bone.2018.02.029.","journal-title":"Bone"},{"key":"1404_CR52","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s11999-010-1578-z","volume":"469","author":"NK Pandya","year":"2011","unstructured":"Pandya NK, Baldwin K, Kamath AF, Wenger DR, Hosalkar HS. Unexplained fractures: child abuse or bone disease? A systematic review. Clin Orthop Relat Res. 2011;469:805\u201312 Association of Bone and Joint Surgeons.","journal-title":"Clin Orthop Relat Res"},{"key":"1404_CR53","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ajhg.2012.06.005","volume":"91","author":"T-J Cho","year":"2012","unstructured":"Cho T-J, Lee K-E, Lee S-K, Song SJ, Kim KJ, Jeon D, et al. A single recurrent mutation in the 5\u2032-UTR of IFITM5 causes Osteogenesis Imperfecta type V. Am J Hum Genet. 2012;91:343\u20138.","journal-title":"Am J Hum Genet"},{"key":"1404_CR54","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ajhg.2012.06.011","volume":"91","author":"O Semler","year":"2012","unstructured":"Semler O, Garbes L, Keupp K, Swan D, Zimmermann K, Becker J, et al. A mutation in the 5\u2032-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant Osteogenesis Imperfecta type V with hyperplastic callus. Am J Hum Genet. 2012;91:349\u201357.","journal-title":"Am J Hum Genet"},{"key":"1404_CR55","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/nar\/25.1.181","volume":"25","author":"R Dalgleish","year":"1997","unstructured":"Dalgleish R. The human type I collagen mutation database. Nucleic Acids Res. 1997;25:181\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1404_CR56","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/jbmr.1891","volume":"28","author":"JR Shapiro","year":"2013","unstructured":"Shapiro JR, Lietman C, Grover M, Lu JT, Nagamani SC, Dawson BC, et al. Phenotypic variability of Osteogenesis Imperfecta type V caused by an IFITM 5 mutation. J Bone Miner Res. 2013;28:1523\u201330.","journal-title":"J Bone Miner Res"},{"key":"1404_CR57","doi-asserted-by":"publisher","first-page":"E8037","DOI":"10.1073\/pnas.1722200115","volume":"115","author":"C Gistelinck","year":"2018","unstructured":"Gistelinck C, Kwon RY, Malfait F, Symoens S, Harris MP, Henke K, et al. Zebrafish type I collagen mutants faithfully recapitulate human type I collagenopathies. Proc Natl Acad Sci U S A. 2018;115:E8037\u201346 National Academy of Sciences.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1404_CR58","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1056\/NEJM198408093110606","volume":"311","author":"DJ Prockop","year":"1984","unstructured":"Prockop DJ, Kivirikko KI. Heritable diseases of collagen. N Engl J Med. 1984;311:376\u201386.","journal-title":"N Engl J Med"},{"key":"1404_CR59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1006\/mgme.2000.3039","volume":"71","author":"A Forlino","year":"2000","unstructured":"Forlino A, Marini JC. Osteogenesis Imperfecta: prospects for molecular therapeutics. Mol Genet Metab. 2000;71:225\u201332.","journal-title":"Mol Genet Metab"},{"key":"1404_CR60","doi-asserted-by":"publisher","first-page":"540178","DOI":"10.4061\/2011\/540178","volume":"2011","author":"IM Ben Amor","year":"2011","unstructured":"Ben Amor IM, Glorieux FH, Rauch F. Genotype-phenotype correlations in autosomal dominant osteogenesis imperfecta. J Osteoporos. 2011;2011:540178 Hindawi Limited.","journal-title":"J Osteoporos"},{"key":"1404_CR61","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3389\/fgene.2019.00722","volume":"10","author":"L Zhytnik","year":"2019","unstructured":"Zhytnik L, Maasalu K, Pashenko A, Khmyzov S, Reimann E, Prans E, et al. COL1A1\/2 pathogenic variants and phenotype characteristics in Ukrainian Osteogenesis Imperfecta patients. Front Genet. 2019;10:722 Frontiers.","journal-title":"Front Genet"},{"key":"1404_CR62","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1021\/bi800026k","volume":"47","author":"DL Bodian","year":"2008","unstructured":"Bodian DL, Madhan B, Brodsky B, Klein TE. Predicting the clinical lethality of osteogenesis imperfecta from collagen glycine mutations. Biochemistry. 2008;47:5424\u201332.","journal-title":"Biochemistry"},{"key":"1404_CR63","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000494491","volume":"84","author":"A Alhousseini","year":"2019","unstructured":"Alhousseini A, Mahaseth M, Zeineddine S, Jaiman S, Berman S, Bryant D, et al. A non-lethal Osteogenesis Imperfecta type II mutation. Gynecol Obstet Investig. 2019;84:204\u20138.","journal-title":"Gynecol Obstet Investig"},{"key":"1404_CR64","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/ejhg.2009.242","volume":"18","author":"F Rauch","year":"2010","unstructured":"Rauch F, Lalic L, Roughley P, Glorieux FH. Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I. Eur J Hum Genet. 2010;18:642\u20137 Nature Publishing Group.","journal-title":"Eur J Hum Genet"},{"key":"1404_CR65","volume-title":"COL1A1\/2-Related Osteogenesis Imperfecta. GeneReviews\u00ae","author":"RD Steiner","year":"1993","unstructured":"Steiner RD, Adsit J, Basel D. COL1A1\/2-Related Osteogenesis Imperfecta. GeneReviews\u00ae. Seattle: University of Washington; 1993."},{"key":"1404_CR66","first-page":"218","volume":"41","author":"N Risch","year":"1987","unstructured":"Risch N, Reich EW, Wishnick MM, McCarthy JG. Spontaneous mutation and parental age in human. Am J Hum Genet. 1987;41:218\u201348.","journal-title":"Am J Hum Genet"},{"key":"1404_CR67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/GIM.0b013e318202e0f6","volume":"13","author":"SM Pyott","year":"2011","unstructured":"Pyott SM, Pepin MG, Schwarze U, Yang K, Smith G, Byers PH. Recurrence of perinatal lethal osteogenesis imperfecta in sibships: parsing the risk between parental mosaicism for dominant mutations and autosomal recessive inheritance. Genet Med. 2011;13:125\u201330.","journal-title":"Genet Med"},{"key":"1404_CR68","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/ccr3.658","volume":"4","author":"AL Frederiksen","year":"2016","unstructured":"Frederiksen AL, Duno M, Johnsen IBG, Nielsen MF, Kr\u00f8ig\u00e5rd AB. Asymptomatic parental mosaicism for osteogenesis imperfecta associated with a new splice site mutation in COL1A2. Clin Case Rep. 2016;4:972\u20138 Wiley-Blackwell.","journal-title":"Clin Case Rep"},{"key":"1404_CR69","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tjog.2013.01.013","volume":"52","author":"C-P Chen","year":"2013","unstructured":"Chen C-P, Lin S-P, Su Y-N, Chern S-R, Su J-W, Wang W. Prenatal diagnosis of recurrent autosomal dominant osteogenesis imperfecta associated with unaffected parents and paternal gonadal mosaicism. Taiwan J Obstet Gynecol. 2013;52:106\u20139.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1404_CR70","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/MOP.0000000000000117","volume":"26","author":"JC Marini","year":"2014","unstructured":"Marini JC, Reich A, Smith SM. Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation. Curr Opin Pediatr. 2014;26:500\u20137.","journal-title":"Curr Opin Pediatr"},{"key":"1404_CR71","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","volume":"127","author":"R Morello","year":"2006","unstructured":"Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, et al. CRTAP is required for Prolyl 3- hydroxylation and mutations cause recessive Osteogenesis Imperfecta. Cell. 2006;127:291\u2013304.","journal-title":"Cell"},{"key":"1404_CR72","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ajhg.2009.09.001","volume":"85","author":"FS van Dijk","year":"2009","unstructured":"van Dijk FS, Nesbitt IM, Zwikstra EH, Nikkels PGJ, Piersma SR, Fratantoni SA, et al. PPIB mutations cause severe Osteogenesis Imperfecta. Am J Hum Genet. 2009;85:521\u20137.","journal-title":"Am J Hum Genet"},{"key":"1404_CR73","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ng1968","volume":"39","author":"WA Cabral","year":"2007","unstructured":"Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, et al. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta. Nat Genet. 2007;39:359\u201365.","journal-title":"Nat Genet"},{"key":"1404_CR74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2350-12-152","volume":"12","author":"OK Steinlein","year":"2011","unstructured":"Steinlein OK, Aichinger E, Trucks H, Sander T. Mutations in FKBP10 can cause a severe form of isolated Osteogenesis imperfecta. BMC Med Genet. 2011;12:152 BioMed Central.","journal-title":"BMC Med Genet"},{"key":"1404_CR75","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2010.01.034","volume":"86","author":"HE Christiansen","year":"2010","unstructured":"Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S, et al. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive Osteogenesis Imperfecta. Am J Hum Genet. 2010;86:389\u201398 The American Society of Human Genetics.","journal-title":"Am J Hum Genet"},{"key":"1404_CR76","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ajhg.2012.02.026","volume":"90","author":"PV Asharani","year":"2012","unstructured":"Asharani PV, Keupp K, Semler O, Wang W, Li Y, Thiele H, et al. Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am J Hum Genet. 2012;90:661\u201374.","journal-title":"Am J Hum Genet"},{"key":"1404_CR77","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ajhg.2015.01.002","volume":"96","author":"L Garbes","year":"2015","unstructured":"Garbes L, Kim K, Rie\u00df A, Hoyer-Kuhn H, Beleggia F, Bevot A, et al. Mutations in SEC24D, encoding a component of the COPII machinery, cause a syndromic form of osteogenesis imperfecta. Am J Hum Genet. 2015;96:432\u20139 The American Society of Human Genetics.","journal-title":"Am J Hum Genet"},{"key":"1404_CR78","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bone.2016.10.023","volume":"94","author":"M Balasubramanian","year":"2017","unstructured":"Balasubramanian M, Hurst J, Brown S, Bishop NJ, Arundel P, DeVile C, et al. Compound heterozygous variants in NBAS as a cause of atypical osteogenesis imperfecta. Bone. 2017;94:65\u201374.","journal-title":"Bone"},{"key":"1404_CR79","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ajmg.a.30231","volume":"131 A","author":"R Ha-Vinh","year":"2004","unstructured":"Ha-Vinh R, Alanay Y, Bank RA, Campos-Xavier AB, Zankl A, Superti-Furga A, et al. Phenotypic and molecular characterization of Bruck syndrome (Osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2. Am J Med Genet. 2004;131 A:115\u201320.","journal-title":"Am J Med Genet"},{"key":"1404_CR80","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ajhg.2011.01.015","volume":"88","author":"J Becker","year":"2011","unstructured":"Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, et al. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 2011;88:362\u201371.","journal-title":"Am J Hum Genet"},{"key":"1404_CR81","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jmedgenet-2017-104999","volume":"55","author":"M Doyard","year":"2018","unstructured":"Doyard M, Bacrot S, Huber C, Di Rocco M, Goldenberg A, Aglan MS, et al. FAM46A mutations are responsible for autosomal recessive osteogenesis imperfecta. J Med Genet. 2018;55:278\u201384.","journal-title":"J Med Genet"},{"key":"1404_CR82","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ajhg.2019.08.008","volume":"105","author":"S Moosa","year":"2019","unstructured":"Moosa S, Yamamoto GL, Garbes L, Keupp K, Beleza-Meireles A, Moreno CA, et al. Autosomal-recessive mutations in MESD cause Osteogenesis Imperfecta. Am J Hum Genet. 2019;105:836\u201343 Cell Press.","journal-title":"Am J Hum Genet"},{"key":"1404_CR83","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1750-1172-8-154","volume":"8","author":"S Symoens","year":"2013","unstructured":"Symoens S, Malfait F, D\u2019hondt S, Callewaert B, Dheedene A, Steyaert W, et al. Deficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humans. Orphanet J Rare Dis. 2013;8:154.","journal-title":"Orphanet J Rare Dis"},{"key":"1404_CR84","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.ajhg.2015.04.021","volume":"96","author":"R Mendoza-Londono","year":"2015","unstructured":"Mendoza-Londono R, Fahiminiya S, Majewski J, T\u00e9treault M, Nadaf J, Kannu P, et al. Recessive Osteogenesis Imperfecta caused by missense mutations in SPARC. Am J Hum Genet. 2015;96:979\u201385.","journal-title":"Am J Hum Genet"},{"key":"1404_CR85","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/jmedgenet-2012-101142","volume":"49","author":"R Shaheen","year":"2012","unstructured":"Shaheen R, Alazami AM, Alshammari MJ, Faqeih E, Alhashmi N, Mousa N, et al. Study of autosomal recessive osteogenesis imperfecta in Arabia reveals a novel locus defined by TMEM38B mutation. J Med Genet. 2012;49:630\u20135.","journal-title":"J Med Genet"},{"key":"1404_CR86","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ajhg.2013.02.009","volume":"92","author":"SM Pyott","year":"2013","unstructured":"Pyott SM, Tran TT, Leistritz DF, Pepin MG, Mendelsohn NJ, Temme RT, et al. WNT1 mutations in families affected by moderately severe and progressive recessive Osteogenesis Imperfecta. Am J Hum Genet. 2013;92:590\u20137 The American Society of Human Genetics.","journal-title":"Am J Hum Genet"},{"key":"1404_CR87","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajhg.2010.05.016","volume":"87","author":"P Lapunzina","year":"2010","unstructured":"Lapunzina P, Aglan M, Temtamy S, Caparr\u00f3s-Mart\u00edn JA, Valencia M, Let\u00f3n R, et al. Identification of a frameshift mutation in osterix in a patient with recessive Osteogenesis Imperfecta. Am J Hum Genet. 2010;87:110\u20134.","journal-title":"Am J Hum Genet"},{"key":"1404_CR88","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/mgg3.331","volume":"6","author":"O Essawi","year":"2018","unstructured":"Essawi O, Symoens S, Fannana M, Darwish M, Farraj M, Willaert A, et al. Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families. Mol Genet Genomic Med. 2018;6:15\u201326.","journal-title":"Mol Genet Genomic Med"},{"key":"1404_CR89","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/jmg.2008.062729","volume":"46","author":"A Willaert","year":"2009","unstructured":"Willaert A, Malfait F, Symoens S, Gevaert K, Kayserili H, Megarbane A, et al. Recessive osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation and identification of the splice form responsible for prolyl 3-hydroxylation. J Med Genet. 2009;46:233\u201341.","journal-title":"J Med Genet"},{"key":"1404_CR90","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/gim.2011.44","volume":"14","author":"WA Cabral","year":"2012","unstructured":"Cabral WA, Barnes AM, Adeyemo A, Cushing K, Chitayat D, Porter FD, et al. A founder mutation in LEPRE1 carried by 1.5% of West Africans and 0.4% of African Americans causes lethal recessive osteogenesis imperfecta. Genet Med. 2012;14:543\u201351.","journal-title":"Genet Med"},{"key":"1404_CR91","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S8756-3282(02)00790-1","volume":"31","author":"LM Ward","year":"2002","unstructured":"Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, et al. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone. 2002;31:12\u20138.","journal-title":"Bone"},{"key":"1404_CR92","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/ajmg.a.37122","volume":"167","author":"ED Kurt-Sukur","year":"2015","unstructured":"Kurt-Sukur ED, Simsek-Kiper PO, Utine GE, Boduroglu K, Alanay Y. Experience of a skeletal dysplasia registry in Turkey: a five-years retrospective analysis. Am J Med Genet A. 2015;167:2065\u201374.","journal-title":"Am J Med Genet A"},{"key":"1404_CR93","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1002\/ajmg.a.38238","volume":"173","author":"AM Ackermann","year":"2017","unstructured":"Ackermann AM, Levine MA. Compound heterozygous mutations in COL1A1 associated with an atypical form of type I osteogenesis imperfecta. Am J Med Genet A. 2017;173:1907\u201312 John Wiley & Sons, Ltd.","journal-title":"Am J Med Genet A"},{"key":"1404_CR94","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s004390050392","volume":"99","author":"A De Paepe","year":"1997","unstructured":"De Paepe A, Nuytinck L, Raes M, Fryns JP. Homozygosity by descent for a COL1A2 mutation in two sibs with severe osteogenesis imperfecta and mild clinical expression in the heterozygotes. Hum Genet. 1997;99:478\u201383.","journal-title":"Hum Genet"},{"key":"1404_CR95","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/jmg.22.6.466","volume":"22","author":"FM Pope","year":"1985","unstructured":"Pope FM, Nicholls AC, McPheat J, Talmud P, Owen R. Collagen genes and proteins in osteogenesis imperfecta. J Med Genet. 1985;22:466\u201378.","journal-title":"J Med Genet"},{"key":"1404_CR96","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ajhg.2013.02.010","volume":"92","author":"K Keupp","year":"2013","unstructured":"Keupp K, Beleggia F, Kayserili H, Barnes AM, Steiner M, Semler O, et al. Mutations in WNT1 cause different forms of bone fragility. Am J Hum Genet. 2013;92:565\u201374.","journal-title":"Am J Hum Genet"},{"key":"1404_CR97","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/gim.2017.115","volume":"20","author":"RB Keller","year":"2018","unstructured":"Keller RB, Tran TT, Pyott SM, Pepin MG, Savarirayan R, McGillivray G, et al. Monoallelic and biallelic CREB3L1 variant causes mild and severe osteogenesis imperfecta, respectively. Genet Med. 2018;20:411\u20139 Nature Publishing Group.","journal-title":"Genet Med"},{"key":"1404_CR98","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/hmg\/ddn374","volume":"18","author":"DL Bodian","year":"2009","unstructured":"Bodian DL, Chan T-F, Poon A, Schwarze U, Yang K, Byers PH, et al. Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships. Hum Mol Genet. 2009;18:463\u201371 Oxford University Press.","journal-title":"Hum Mol Genet"},{"key":"1404_CR99","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/hmg\/ddr037","volume":"20","author":"SM Pyott","year":"2011","unstructured":"Pyott SM, Schwarze U, Christiansen HE, Pepin MG, Leistritz DF, Dineen R, et al. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes. Hum Mol Genet. 2011;20:1595\u2013609.","journal-title":"Hum Mol Genet"},{"key":"1404_CR100","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa1308223","volume":"369","author":"FS van Dijk","year":"2013","unstructured":"van Dijk FS, Zillikens MC, Micha D, Riessland M, Marcelis CLM, de Die-Smulders CE, et al. PLS3 mutations in X-linked osteoporosis with fractures. N Engl J Med. 2013;369:1529\u201336.","journal-title":"N Engl J Med"},{"key":"1404_CR101","doi-asserted-by":"publisher","first-page":"11920","DOI":"10.1038\/ncomms11920","volume":"7","author":"U Lindert","year":"2016","unstructured":"Lindert U, Cabral WA, Ausavarat S, Tongkobpetch S, Ludin K, Barnes AM, et al. MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta. Nat Commun. 2016;7:11920.","journal-title":"Nat Commun"},{"issue":"9","key":"1404_CR102","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41576-019-0134-2","volume":"20","author":"Stylianos E. Antonarakis","year":"2019","unstructured":"Antonarakis SE. Carrier screening for recessive disorders. Nat Rev Genet. 2019;20:549\u201361. https:\/\/doi.org\/10.1038\/s41576-019-0134-2.","journal-title":"Nature Reviews Genetics"},{"issue":"2","key":"1404_CR103","doi-asserted-by":"publisher","first-page":"a011775","DOI":"10.1101\/cshperspect.a011775","volume":"3","author":"A Cao","year":"2013","unstructured":"Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013;3(2):a011775.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1404_CR104","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/pd.5109","volume":"38","author":"D Chokoshvili","year":"2018","unstructured":"Chokoshvili D, Vears D, Borry P. Expanded carrier screening for monogenic disorders: where are we now? Prenat Diagn. 2018;38:59\u201366 John Wiley and Sons Ltd.","journal-title":"Prenat Diagn"},{"issue":"12","key":"1404_CR105","doi-asserted-by":"publisher","first-page":"e114391","DOI":"10.1371\/journal.pone.0114391","volume":"9","author":"GA Lazarin","year":"2014","unstructured":"Lazarin GA, Hawthorne F, Collins NS, Platt EA, Evans EA, Haque IS. Systematic classification of disease severity for evaluation of expanded carrier screening panels. PLoS One. 2014;9(12):e114391 Public Library of Science.","journal-title":"PLoS One"},{"issue":"S3","key":"1404_CR106","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1007\/PL00014401","volume":"159","author":"Michael M. Kaback","year":"2000","unstructured":"Kaback MM. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. Eur J Pediatr. 2000;159:S192\u2013S195. https:\/\/doi.org\/10.1007\/PL00014401.","journal-title":"European Journal of Pediatrics"},{"key":"1404_CR107","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1001\/jama.1997.03550150077039","volume":"278","author":"A Cao","year":"1997","unstructured":"Cao A, Saba L, Galanello R, Rosatelli MC. Molecular diagnosis and carrier screening for beta thalassemia. JAMA. 1997;278:1273\u20137.","journal-title":"JAMA"},{"key":"1404_CR108","doi-asserted-by":"publisher","unstructured":"American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 486: Update on Carrier Screening forCystic Fibrosis, Obstetrics & Gynecology. 2011;117(4):1028\u201331. https:\/\/doi.org\/10.1097\/AOG.0b013e31821922c2.","DOI":"10.1097\/AOG.0b013e31821922c2"},{"key":"1404_CR109","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41431-017-0056-4","volume":"26","author":"IB Mathijssen","year":"2018","unstructured":"Mathijssen IB, Holtkamp KCA, Ottenheim CPE, Van Eeten-Nijman JMC, Lakeman P, Meijers-Heijboer H, et al. Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population \/631\/208\/2489\/1512 \/692\/700\/478\/2772 article. Eur J Hum Genet. 2018;26:166\u201375 Nature Publishing Group.","journal-title":"Eur J Hum Genet"},{"key":"1404_CR110","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/mgg3.21","volume":"1","author":"MG Pepin","year":"2013","unstructured":"Pepin MG, Schwarze U, Singh V, Romana M, Jones-LeCointe A, Byers PH. Allelic background of LEPRE1 mutations that cause recessive forms of osteogenesis imperfecta in different populations. Mol Genet Genomic Med. 2013;1:194\u2013205.","journal-title":"Mol Genet Genomic Med"},{"key":"1404_CR111","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1215458","volume":"368","author":"CM Laine","year":"2013","unstructured":"Laine CM, Joeng KS, Campeau PM, Kiviranta R, Tarkkonen K, Grover M, et al. WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta. N Engl J Med. 2013;368:1809\u201316.","journal-title":"N Engl J Med"},{"key":"1404_CR112","doi-asserted-by":"publisher","first-page":"n\/a","DOI":"10.1002\/humu.22274","volume":"34","author":"M Volodarsky","year":"2013","unstructured":"Volodarsky M, Markus B, Cohen I, Staretz-Chacham O, Flusser H, Landau D, et al. A deletion mutation in TMEM38B associated with autosomal recessive Osteogenesis Imperfecta. Hum Mutat. 2013;34:n\/a.","journal-title":"Hum Mutat"},{"key":"1404_CR113","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ajhg.2010.02.022","volume":"86","author":"Y Alanay","year":"2010","unstructured":"Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, et al. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive Osteogenesis Imperfecta. Am J Hum Genet. 2010;86:551\u20139 The American Society of Human Genetics.","journal-title":"Am J Hum Genet"},{"key":"1404_CR114","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/ejhg.2016.43","volume":"24","author":"M Plantinga","year":"2016","unstructured":"Plantinga M, Birnie E, Abbott KM, Sinke RJ, Lucassen AM, Schuurmans J, et al. Population-based preconception carrier screening: how potential users from the general population view a test for 50 serious diseases. Eur J Hum Genet. 2016;24:1417\u201323 Nature Publishing Group.","journal-title":"Eur J Hum Genet"},{"issue":"65","key":"1404_CR115","doi-asserted-by":"publisher","first-page":"65ra4","DOI":"10.1126\/scitranslmed.3001756","volume":"3","author":"CJ Bell","year":"2011","unstructured":"Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med. 2011;3(65):65ra4.","journal-title":"Sci Transl Med"},{"key":"1404_CR116","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.rbmo.2010.05.012","volume":"21","author":"BS Srinivasan","year":"2010","unstructured":"Srinivasan BS, Evans EA, Flannick J, Patterson AS, Chang CC, Pham T, et al. A universal carrier test for the long tail of Mendelian disease. Reprod BioMed Online. 2010;21:537\u201351.","journal-title":"Reprod BioMed Online"},{"key":"1404_CR117","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/ard.59.3.166","volume":"59","author":"AA Deodhar","year":"2000","unstructured":"Deodhar AA, Woolf AD. Fragile without fractures. Ann Rheum Dis. 2000;59:166\u201371 BMJ Publishing Group Ltd.","journal-title":"Ann Rheum Dis"},{"key":"1404_CR118","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00264-016-3315-z","volume":"41","author":"HD Binh","year":"2017","unstructured":"Binh HD, Maasalu K, Dung VC, Ngoc CTB, Hung TT, Nam TV, et al. The clinical features of osteogenesis imperfecta in Vietnam. Int Orthop. 2017;41:21\u20139.","journal-title":"Int Orthop"},{"key":"1404_CR119","unstructured":"Parikh JH, Skreydel M, Mozlin R. Diving deeper into the blue: a case of osteogenesis imperfecta with ocular involvement undiagnosed for 25 years. American Academy of Optometry. 2017. Abstract."},{"key":"1404_CR120","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/IMCRJ.S17929","volume":"4","author":"M Rebelo","year":"2011","unstructured":"Rebelo M, Lima J, Vieira JD, Costa JN. An unusual presentation of osteogenesis imperfecta type I. Int Med Case Rep J. 2011;4:25\u20139.","journal-title":"Int Med Case Rep J"},{"key":"1404_CR121","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ajhg.2014.07.003","volume":"95","author":"IM Campbell","year":"2014","unstructured":"Campbell IM, Yuan B, Robberecht C, Pfundt R, Szafranski P, McEntagart ME, et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am J Hum Genet. 2014;95:173\u201382 Cell Press.","journal-title":"Am J Hum Genet"},{"key":"1404_CR122","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/ejhg.2015.271","volume":"24","author":"L Henneman","year":"2016","unstructured":"Henneman L, Borry P, Chokoshvili D, Cornel MC, Van El CG, Forzano F, et al. Responsible implementation of expanded carrier screening. Eur J Hum Genet. 2016;24:e1\u201312 Nature Publishing Group.","journal-title":"Eur J Hum Genet"},{"key":"1404_CR123","doi-asserted-by":"publisher","first-page":"e20154514","DOI":"10.1542\/peds.2015-4514","volume":"137","author":"A Kidszun","year":"2016","unstructured":"Kidszun A, Linebarger J, Walter JK, Paul NW, Fruth A, Mildenberger E, et al. What if the prenatal diagnosis of a lethal anomaly turns out to be wrong? Pediatrics. 2016;137:e20154514.","journal-title":"Pediatrics"},{"issue":"3","key":"1404_CR124","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00404-017-4291-2","volume":"295","author":"JB Qin","year":"2017","unstructured":"Qin JB, Sheng XQ, Wang H, Chen GC, Yang J, Yu H, et al. Worldwide prevalence of adverse pregnancy outcomes associated with in vitro fertilization\/intracytoplasmic sperm injection among multiple births: a systematic review and meta-analysis based on cohort studies. Arch Gynecol Obstet. 2017;295(3):577\u201397 Springer Verlag.","journal-title":"Arch Gynecol Obstet"},{"key":"1404_CR125","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1111\/1471-0528.14365","volume":"124","author":"M Davies","year":"2017","unstructured":"Davies M, Rumbold A, Marino J, Willson K, Giles L, Whitrow M, et al. Maternal factors and the risk of birth defects after IVF and ICSI: a whole of population cohort study. BJOG An Int J Obstet Gynaecol. 2017;124:1537\u201344.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"1404_CR126","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/aogs.13541","volume":"98","author":"M Banker","year":"2019","unstructured":"Banker M, Arora P, Banker J, Benani H, Shah S, Lalitkumar PGL. Prevalence of structural birth defects in IVF-ICSI pregnancies resulting from autologous and donor oocytes in Indian sub-continent: results from 2444 births. Acta Obstet Gynecol Scand. 2019;98:715\u201321 Wiley-Blackwell.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"1404_CR127","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02072526","volume":"13","author":"Yury Verlinsky","year":"1996","unstructured":"Zamani Esteki M, Viltrop T, T\u0161uiko O, Tiirats A, Koel M, N\u00f5ukas M, et al. In vitro fertilization does not increase the incidence of de novo copy number alterations in fetal and placental lineages. Nat Med. 2019;25:1699\u2013705. https:\/\/doi.org\/10.1007\/BF02072526.","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"1404_CR128","unstructured":"Oocyte donation - Fertility - NCBI Bookshelf. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK327787\/. Cited 9 Dec 2019."},{"key":"1404_CR129","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.18632\/aging.101449","volume":"10","author":"J Zhang","year":"2018","unstructured":"Zhang J, Lai Z, Shi L, Tian Y, Luo A, Xu Z, et al. Repeated superovulation increases the risk of osteoporosis and cardiovascular diseases by accelerating ovarian aging in mice. Aging (Albany. NY). 2018;10:1089\u2013102 Impact Journals LLC.","journal-title":"Aging (Albany. NY)"},{"issue":"2","key":"1404_CR130","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02072526","volume":"13","author":"Yury Verlinsky","year":"1996","unstructured":"Verlinsky Y. Preimplantation genetic diagnosis. J Assist Reprod Genet. 1996;13:87\u20139. https:\/\/doi.org\/10.1007\/BF02072526.","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"1404_CR131","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-genom-091416-035508","volume":"18","author":"NR Treff","year":"2017","unstructured":"Treff NR, Zimmerman RS. Advances in preimplantation genetic testing for monogenic disease and aneuploidy. Annu Rev Genomics Hum Genet. 2017;18:189\u2013200 Annual Review.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"8","key":"1404_CR132","doi-asserted-by":"publisher","first-page":"103647","DOI":"10.1016\/j.ejmg.2019.04.004","volume":"62","author":"NR Treff","year":"2019","unstructured":"Treff NR, Zimmerman R, Bechor E, Hsu J, Rana B, Jensen J, et al. Validation of concurrent preimplantation genetic testing for polygenic and monogenic disorders, structural rearrangements, and whole and segmental chromosome aneuploidy with a single universal platform. Eur J Med Genet. 2019;62(8):103647 Elsevier Masson SAS.","journal-title":"Eur J Med Genet"},{"issue":"1","key":"1404_CR133","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ogc.2017.10.009","volume":"45","author":"C Sullivan-Pyke","year":"2018","unstructured":"Sullivan-Pyke C, Dokras A. Preimplantation genetic screening and preimplantation genetic diagnosis. Obstet Gynecol Clin North Am. 2018;45(1):113\u201325 W.B. Saunders.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"1404_CR134","first-page":"99","volume":"35","author":"M Jee Kim","year":"2008","unstructured":"Jee Kim M, Lee H-S, Won Choi H, Kyu Lim C, Won Cho J, Young Kim J, et al. Establishment and application of molecular genetic techniques for preimplantation genetic diagnosis of Osteogenesis Imperfecta. Korean J Reprod Med. 2008;35:99\u2013110.","journal-title":"Korean J Reprod Med"},{"key":"1404_CR135","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/molehr\/gag051","volume":"9","author":"W Piyamongkol","year":"2003","unstructured":"Piyamongkol W. Detailed investigation of factors influencing amplification efficiency and allele drop-out in single cell PCR: implications for preimplantation genetic diagnosis. Mol Hum Reprod. 2003;9:411\u201320 Oxford University Press (OUP).","journal-title":"Mol Hum Reprod"},{"issue":"12","key":"1404_CR136","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/14737159.2017.1394186","volume":"17","author":"A Kuliev","year":"2017","unstructured":"Kuliev A, Rechitsky S. Preimplantation genetic testing: current challenges and future prospects. Expert Rev Mol Diagn. 2017;17(12):1071\u201388 Taylor and Francis Ltd.","journal-title":"Expert Rev Mol Diagn"},{"key":"1404_CR137","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.fertnstert.2014.11.007","volume":"103","author":"S Rechitsky","year":"2015","unstructured":"Rechitsky S, Pakhalchuk T, San Ramos G, Goodman A, Zlatopolsky Z, Kuliev A. First systematic experience of preimplantation genetic diagnosis for single-gene disorders, and\/or preimplantation human leukocyte antigen typing, combined with 24-chromosome aneuploidy testing. Fertil Steril. 2015;103:503\u201312 Elsevier Inc.","journal-title":"Fertil Steril"},{"key":"1404_CR138","first-page":"37","volume":"7","author":"PR Brezina","year":"2013","unstructured":"Brezina PR, Ke RW, Kutteh WH. Preimplantation genetic screening: a practical guide. Clin Med Insights Reprod Health. 2013;7:37\u201342.","journal-title":"Clin Med Insights Reprod Health"},{"issue":"9765","key":"1404_CR139","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(11)60201-8","volume":"377","author":"C Schaaf","year":"2011","unstructured":"Schaaf C, Scott D, Wiszniewska J, Beaudet A. Identification of incestuous parental relationships by SNP-based DNA microarrays. Lancet. 2011;377(9765):555\u20136.","journal-title":"Lancet"},{"key":"1404_CR140","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/gim.2014.45","volume":"16","author":"SA Natesan","year":"2014","unstructured":"Natesan SA, Bladon AJ, Coskun S, Qubbaj W, Prates R, Munne S, et al. Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. Genet Med. 2014;16:838\u201345 Nature Publishing Group.","journal-title":"Genet Med"},{"key":"1404_CR141","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/19396368.2018.1472315","volume":"65","author":"L Chen","year":"2019","unstructured":"Chen L, Diao Z, Xu Z, Zhou J, Yan G, Sun H. The clinical application of single-sperm-based SNP haplotyping for PGD of osteogenesis imperfecta. Syst Biol Reprod Med. 2019;65:75\u201380 Taylor and Francis Ltd.","journal-title":"Syst Biol Reprod Med"},{"key":"1404_CR142","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1472-6483(10)62024-X","volume":"13","author":"PJ Renwick","year":"2006","unstructured":"Renwick PJ, Trussler J, Ostad-Saffari E, Fassihi H, Black C, Braude P, et al. Proof of principle and first cases using preimplantation genetic haplotyping - a paradigm shift for embryo diagnosis. Reprod Biomed Online. 2006;13:110\u20139 Reproductive Healthcare Ltd.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"1404_CR143","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00439-011-1056-z","volume":"131","author":"JC Harper","year":"2012","unstructured":"Harper JC, Sengupta SB. Preimplantation genetic diagnosis: State of the ART 2011. Hum Genet. 2012;131(2):175\u201386.","journal-title":"Hum Genet"},{"key":"1404_CR144","first-page":"99","volume":"23","author":"BF Zanetti","year":"2019","unstructured":"Zanetti BF, Braga DPDAF, Azevedo MDC, Setti AS, Figueira RCS, Iaconelli A, et al. Preimplantation genetic testing for monogenic diseases: a Brazilian IVF centre experience. J Bras Reprod Assist. 2019;23:99\u2013105 Sociedade Brasileira de Reproducao Assistida.","journal-title":"J Bras Reprod Assist"},{"issue":"1","key":"1404_CR145","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.fertnstert.2015.09.042","volume":"105","author":"PR Brezina","year":"2016","unstructured":"Brezina PR, Kutteh WH, Bailey AP, Ke RW. Preimplantation genetic screening (PGS) is an excellent tool, but not perfect: a guide to counseling patients considering PGS. Fertil Steril. 2016;105(1):49\u201350 Elsevier Inc.","journal-title":"Fertil Steril"},{"key":"1404_CR146","doi-asserted-by":"publisher","DOI":"10.4172\/2375-4508.1000116","volume-title":"Safety, accuracy and reproductive outcome of preimplantation genetic diagnosis","author":"A Kuliev","year":"2013","unstructured":"Kuliev A, Verlinsky O, Rechitsky S. Safety, accuracy and reproductive outcome of preimplantation genetic diagnosis; 2013."},{"issue":"1","key":"1404_CR147","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40778-018-0118-8","volume":"4","author":"R Sagar","year":"2018","unstructured":"Sagar R, Walther-Jallow L, David AL, G\u00f6therstr\u00f6m C, Westgren M. Fetal mesenchymal stromal cells: an opportunity for prenatal cellular therapy. Curr Stem Cell Rep. 2018;4(1):61\u20138 Springer International Publishing.","journal-title":"Curr Stem Cell Rep"},{"key":"1404_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1988.tb55311.x","volume":"543","author":"DO Sillence","year":"1988","unstructured":"Sillence DO. Osteogenesis Imperfecta nosology and genetics. Ann N Y Acad Sci. 1988;543:1\u201316.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1404_CR149","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.gene.2012.04.045","volume":"504","author":"A Bustamante-Aragon\u00e9s","year":"2012","unstructured":"Bustamante-Aragon\u00e9s A, Rodr\u00edguez de Alba M, Perlado S, Trujillo-Tiebas MJ, Arranz JP, D\u00edaz-Recasens J, et al. Non-invasive prenatal diagnosis of single-gene disorders from maternal blood. Gene. 2012;504(1):144\u20139.","journal-title":"Gene"},{"key":"1404_CR150","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1373\/clinchem.2008.111385","volume":"54","author":"FMF Lun","year":"2008","unstructured":"Lun FMF, Chiu RWK, Chan KCA, Tak YL, Tze KL, Lo YMD. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem. 2008;54:1664\u201372.","journal-title":"Clin Chem"},{"key":"1404_CR151","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/pd.1700","volume":"27","author":"M Alberry","year":"2007","unstructured":"Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn. 2007;27:415\u20138.","journal-title":"Prenat Diagn"},{"key":"1404_CR152","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1373\/clinchem.2003.024893","volume":"50","author":"KCA Chan","year":"2004","unstructured":"Chan KCA, Zhang J, Hui ABY, Wong N, Lau TK, Leung TN, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem. 2004;50:88\u201392.","journal-title":"Clin Chem"},{"key":"1404_CR153","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/humrep\/deg320","volume":"18","author":"J Guibert","year":"2003","unstructured":"Guibert J, Benachi A, Grebille AG, Ernault P, Zorn JR, Costa JM. Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique. Hum Reprod. 2003;18:1733\u20136 Oxford University Press.","journal-title":"Hum Reprod"},{"issue":"3","key":"1404_CR154","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1590\/1678-4685-gmb-2017-0177","volume":"41","author":"Carolina Malcher","year":"2018","unstructured":"Malcher C, Yamamoto GL, Burnham P, Ezquina SAM, Louren\u00e7o NCV, Balkassmi S, et al. Development of a comprehensive noninvasive prenatal test. Genet Mol Biol. 2018;41(3):545\u201354. https:\/\/doi.org\/10.1590\/1678-4685-gmb-2017-0177.","journal-title":"Genetics and Molecular Biology"},{"key":"1404_CR155","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1373\/clinchem.2015.252502","volume":"62","author":"G Koumbaris","year":"2016","unstructured":"Koumbaris G, Kypri E, Tsangaras K, Achilleos A, Mina P, Neofytou M, et al. Cell-Free DNA analysis of targeted genomic regions in maternal plasma for non-invasive prenatal testing of trisomy 21, trisomy 18, trisomy 13, and fetal sex. Clin Chem. 2016;62:848\u201355 American Association for Clinical Chemistry Inc.","journal-title":"Clin Chem"},{"key":"1404_CR156","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/pd.5578","volume":"39","author":"O \u017dilina","year":"2019","unstructured":"\u017dilina O, Rekker K, Kaplinski L, Sauk M, Paluoja P, Teder H, et al. Creating basis for introducing non-invasive prenatal testing in the Estonian public health setting. Prenat Diagn. 2019;39:1262\u20138 John Wiley and Sons Ltd.","journal-title":"Prenat Diagn"},{"issue":"7","key":"1404_CR157","doi-asserted-by":"publisher","first-page":"e0209139","DOI":"10.1371\/journal.pone.0209139","volume":"14","author":"H Teder","year":"2019","unstructured":"Teder H, Paluoja P, Rekker K, Salumets A, Krjut\u0161kov K, Palta P. Computational framework for targeted high-coverage sequencing based NIPT. PLoS One. 2019;14(7):e0209139 Public Library of Science.","journal-title":"PLoS One"},{"issue":"3","key":"1404_CR158","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41591-018-0334-x","volume":"25","author":"J Zhang","year":"2019","unstructured":"Zhang J, Li J, Saucier JB, Feng Y, Jiang Y, Sinson J, et al. Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA. Nat Med. 2019;25(3):439\u201347 Nature Publishing Group.","journal-title":"Nat Med"},{"issue":"2","key":"1404_CR159","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40291-019-00385-2","volume":"23","author":"G Breveglieri","year":"2019","unstructured":"Breveglieri G, D\u2019Aversa E, Finotti A, Borgatti M. Non-invasive prenatal testing using fetal DNA. Mol Diagnosis Ther. 2019;23(2):291\u20139 Springer International Publishing.","journal-title":"Mol Diagnosis Ther"},{"issue":"7","key":"1404_CR160","doi-asserted-by":"publisher","first-page":"e0159355","DOI":"10.1371\/journal.pone.0159355","volume":"11","author":"S Dan","year":"2016","unstructured":"Dan S, Yuan Y, Wang Y, Chen C, Gao C, Yu S, et al. Non-invasive prenatal diagnosis of lethal skeletal dysplasia by targeted capture sequencing of maternal plasma. PLoS One. 2016;11(7):e0159355 Public Library of Science.","journal-title":"PLoS One"},{"key":"1404_CR161","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1055\/s-2007-963217","volume":"29","author":"P Kozlowski","year":"2008","unstructured":"Kozlowski P, Knippel A, Stressig R. Individual risk of fetal loss following routine second trimester amniocentesis: a controlled study of 20 460 cases. Ultraschall der Medizin. 2008;29:165\u201372.","journal-title":"Ultraschall der Medizin"},{"key":"1404_CR162","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1203\/00006450-199410000-00005","volume":"36","author":"M Raghunath","year":"1994","unstructured":"Raghunath M, Steinmann B, Delozier-Blanchet C, Extermann P, Superti-Furga A. Prenatal diagnosis of collagen disorders by direct biochemical analysis of chorionic villus biopsies. Pediatr Res. 1994;36:441\u20138.","journal-title":"Pediatr Res"},{"key":"1404_CR163","doi-asserted-by":"publisher","unstructured":"Alfirevic Z, Navaratnam K, Mujezinovic F. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2017;9(9):CD003252. Published 2017 Sep 4. https:\/\/doi.org\/10.1002\/14651858.CD003252.pub2.","DOI":"10.1002\/14651858.CD003252.pub2"},{"key":"1404_CR164","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5317\/wjog.v5.i1.58","volume":"5","author":"KA Connolly","year":"2016","unstructured":"Connolly KA. Amniocentesis: a contemporary review. World J Obstet Gynecol. 2016;5:58 Baishideng Publishing Group Inc.","journal-title":"World J Obstet Gynecol"},{"key":"1404_CR165","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.ejhg.5201774","volume":"15","author":"M Decruyenaere","year":"2007","unstructured":"Decruyenaere M, Evers-Kiebooms G, Boogaerts A, Philippe K, Demyttenaere K, Dom R, et al. The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation. Eur J Hum Genet. 2007;15:453\u201362.","journal-title":"Eur J Hum Genet"},{"key":"1404_CR166","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s10038-017-0379-6","volume":"63","author":"Z Moudi","year":"2018","unstructured":"Moudi Z, Phanodi Z, Ansari H, Zohour MM. Decisional conflict and regret: shared decision-making about pregnancy affected by \u03b2-thalassemia major in southeast of Iran. J Hum Genet. 2018;63:309\u201317 Nature Publishing Group.","journal-title":"J Hum Genet"},{"key":"1404_CR167","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10897-005-0619-3","volume":"14","author":"C Downing","year":"2005","unstructured":"Downing C. Negotiating responsibility: case studies of reproductive decision-making and prenatal genetic testing in families facing Huntington disease. J Genet Couns. 2005;14:219\u201334.","journal-title":"J Genet Couns"},{"key":"1404_CR168","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.fertnstert.2005.01.090","volume":"83","author":"AL Kalfoglou","year":"2005","unstructured":"Kalfoglou AL, Doksum T, Bernhardt B, Geller G, LeRoy L, Mathews DJH, et al. Opinions about new reproductive genetic technologies: hopes and fears for our genetic future. Fertil Steril. 2005;83:1612\u201321.","journal-title":"Fertil Steril"},{"key":"1404_CR169","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.rbms.2016.11.002","volume":"3","author":"B Bock von W\u00fclfingen","year":"2016","unstructured":"Bock von W\u00fclfingen B. Contested change: how Germany came to allow PGD. Reprod Biomed Soc Online. 2016;3:60\u20137 Elsevier Ltd.","journal-title":"Reprod Biomed Soc Online"},{"key":"1404_CR170","unstructured":"PGD conditions | Human Fertilisation and Embryology Authority. Available from: https:\/\/www.hfea.gov.uk\/pgd-conditions\/. Cited 16 Apr 2020."},{"key":"1404_CR171","doi-asserted-by":"publisher","first-page":"979","DOI":"10.5124\/jkma.2015.58.11.979","volume":"58","author":"JY Kim","year":"2015","unstructured":"Kim JY, Lee HS, Kang IS. Preimplantation genetic diagnosis. J Korean Med Assoc. 2015;58:979\u201388 Korean Medical Association.","journal-title":"J Korean Med Assoc"},{"issue":"5","key":"1404_CR172","doi-asserted-by":"publisher","first-page":"a036681","DOI":"10.1101\/cshperspect.a036681","volume":"10","author":"Margaret E.C. Ginoza","year":"2019","unstructured":"Ginoza MEC, Isasi R. Regulating preimplantation genetic testing across the world: a comparison of international policy and ethical perspectives. Cold Spring Harb Perspect Med. 2019. https:\/\/doi.org\/10.1101\/cshperspect.a036681 Cold Spring Harbor Laboratory.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"1404_CR173","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.rbms.2017.01.001","volume":"3","author":"MJ Bayefsky","year":"2016","unstructured":"Bayefsky MJ. Comparative preimplantation genetic diagnosis policy in Europe and the USA and its implications for reproductive tourism. Reprod Biomed Soc Online. 2016;3:41\u20137 Elsevier Ltd.","journal-title":"Reprod Biomed Soc Online"},{"issue":"2","key":"1404_CR174","first-page":"119","volume":"28","author":"P Benn","year":"2016","unstructured":"Benn P, Chapman AR. Ethical and practical challenges in providing noninvasive prenatal testing for chromosome abnormalities: an update. Curr Opin Obstet Gynecol. 2016;28(2):119\u201324 Lippincott Williams and Wilkins.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"1404_CR175","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12687-018-0371-7","volume":"10","author":"AJ Clarke","year":"2019","unstructured":"Clarke AJ, Wallgren-Pettersson C. Ethics in genetic counselling. J Community Genet. 2019;10(1):3\u201333 Springer Verlag.","journal-title":"J Community Genet"},{"issue":"4","key":"1404_CR176","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/01.gim.0000215177.28010.6e","volume":"8","author":"CA James","year":"2006","unstructured":"James CA, Hadley DW, Holtzman NA, Winkelstein JA. How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X-linked and autosomal recessive diseases. Genet Med. 2006;8(4):234\u201342 Nature Publishing Group.","journal-title":"Genet Med"},{"issue":"10","key":"1404_CR177","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/pd.4647","volume":"35","author":"SB Nazareth","year":"2015","unstructured":"Nazareth SB, Lazarin GA, Goldberg JD. Changing trends in carrier screening for genetic disease in the United States. Prenat Diagn. 2015;35(10):931\u20135 John Wiley and Sons Ltd.","journal-title":"Prenat Diagn"},{"key":"1404_CR178","unstructured":"Dollar EP. No easy choice : a story of disability, parenthood, and faith in an age of advanced reproduction. Louisville: Westminster John Knox Press; 2012."},{"issue":"5","key":"1404_CR179","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.siny.2014.08.007","volume":"19","author":"D Wilkinson","year":"2014","unstructured":"Wilkinson D, de Crespigny L, Xafis V. Ethical language and decision-making for prenatally diagnosed lethal malformations. Semin Fetal Neonatal Med. 2014;19(5):306\u201311.","journal-title":"Semin Fetal Neonatal Med"},{"key":"1404_CR180","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1701-2163(15)30568-5","volume":"36","author":"M Vanstone","year":"2014","unstructured":"Vanstone M, King C, de Vrijer B, Nisker J. Non-invasive prenatal testing: ethics and policy considerations. J Obstet Gynaecol Can. 2014;36:515\u201326 Elsevier Inc.","journal-title":"J Obstet Gynaecol Can"},{"key":"1404_CR181","unstructured":"Non-invasive prenatal testing - The Nuffield Council on Bioethics. Available from: https:\/\/nuffieldbioethics.org\/publications\/non-invasive-prenatal-testing. Cited 16 Jan 2020."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01404-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01404-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01404-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T23:42:45Z","timestamp":1622072565000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01404-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":181,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01404-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}